- Email: [email protected]
Corrigendum to “Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)” [Int. J. Pharm. 498 (2016) 326–334]
International Journal of Pharmaceutics 509 (2016) 528
Contents lists available at ScienceDirect
International Journal of Pharmaceutics journal homepage: www.elsevier.com/locate/ijpharm
Corrigendum
Corrigendum to “Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)” [Int. J. Pharm. 498 (2016) 326–334] Kishore Cholkar a,c , Brian C. Gilger b , Ashim K. Mitra a,∗ a
Division of Pharmaceutical Sciences, School of Pharmacy, 5258 Health Science Building, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA b North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA c RiconPharma LLC, Suite 9, Denville, NJ 07834, USA
The authors regret that Figure 2 did not contain the part B in the published article. Below is the part B of Figure 2. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.ijpharm.2015.12.037. ∗ Corresponding author at: Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri Kansas City, 2464 Charlotte Street, Kansas City, MO 64108-2718, USA. Fax: +1 816 235 5779. E-mail address: [email protected] (A.K. Mitra). http://dx.doi.org/10.1016/j.ijpharm.2016.04.012 0378-5173/© 2016 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Pharmaceutics journal homepage: www.elsevier.com/locate/ijpharm
Corrigendum
Corrigendum to “Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)” [Int. J. Pharm. 498 (2016) 326–334] Kishore Cholkar a,c , Brian C. Gilger b , Ashim K. Mitra a,∗ a
Division of Pharmaceutical Sciences, School of Pharmacy, 5258 Health Science Building, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA b North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA c RiconPharma LLC, Suite 9, Denville, NJ 07834, USA
The authors regret that Figure 2 did not contain the part B in the published article. Below is the part B of Figure 2. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.ijpharm.2015.12.037. ∗ Corresponding author at: Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri Kansas City, 2464 Charlotte Street, Kansas City, MO 64108-2718, USA. Fax: +1 816 235 5779. E-mail address: [email protected] (A.K. Mitra). http://dx.doi.org/10.1016/j.ijpharm.2016.04.012 0378-5173/© 2016 Elsevier B.V. All rights reserved.